Anzeige
Mehr »
Login
Mittwoch, 29.01.2020 Börsentäglich über 12.000 News von 622 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A140ML ISIN: JE00BYSS4X48 Ticker-Symbol: 038 
Tradegate
28.01.20
21:39 Uhr
79,34 Euro
+0,38
+0,48 %
1-Jahres-Chart
NOVOCURE LIMITED Chart 1 Jahr
5-Tage-Chart
NOVOCURE LIMITED 5-Tage-Chart
RealtimeGeldBriefZeit
78,50
80,06
08:25

Aktuelle News zur NOVOCURE Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
NOVOCURE Aktie jetzt für 4€ handeln
21.01.Reimbursement for NovoCure's Optune set in Israel5
21.01.Novocure Announces National Reimbursement in Israel for Optune in Combination with Temozolomide for the Treatment of Newly Diagnosed Glioblastoma252Novocure (NASDAQ: NVCR) announced today that the State of Israel Ministry of Health has added Optune in combination with temozolomide to the Israeli medical services basket for the treatment of patients...
► Artikel lesen
16.01.Here's Why NovoCure Stock Is Up Big Today21
14.01.NovoCure (NVCR) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow6
13.01.NovoCure Ltd - 8-K, Current Report5
13.01.Novocure announces preliminary 2019 results and corporate update9
09.01.Zai Lab Limited: Zai Lab and Novocure Announce First Patient Enrolled in a Phase 2 Pilot Trial of Tumor Treating Fields Together with Chemotherapy as ...10
09.01.Zai Lab and Novocure Announce First Patient Enrolled in a Phase 2 Pilot Trial of Tumor Treating Fields Together with Chemotherapy as First-Line Treatment of Gastric Cancer292Zai Lab Limited (NASDAQ: ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, and Novocure (NASDAQ: NVCR), a global oncology company with a proprietary platform technology...
► Artikel lesen
09.01.Why NovoCure Stock Skyrocketed 152% in 20192
06.01.Buy NovoCure: The First Mover In The New Modality In Cancer Treatment8
03.01.NovoCure: I Still Like What I See10
02.01.Here's Why Novocure Slipped Lower Today12
26.12.19Novocure to Participate in the 38th Annual J.P. Morgan Healthcare Conference362Novocure (NASDAQ: NVCR) will participate in the 38th Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2020, in San Francisco. William Doyle, Novocure's Executive Chairman, will speak...
► Artikel lesen
19.12.19NovoCure Making Remarkable Progress; Buy16
04.12.19Why NovoCure Stock Soared 29% in November17
02.12.19Novocure and the AACR Announce 2nd Annual AACR-Novocure Grants for Tumor Treating Fields Research Program260The program includes research grants and career development awards totaling more than $2 million over the next three years Novocure (NASDAQ: NVCR) and the American Association for Cancer Research...
► Artikel lesen
26.11.19Novocure to Participate in the Evercore ISI 2019 HealthCONx Conference284Novocure (NASDAQ: NVCR) announced today that William Doyle, Novocure's Executive Chairman, will participate in the Evercore ISI 2019 HealthCONx Conference on December 5, 2019, in Boston. Mr. Doyle's...
► Artikel lesen
20.11.19Novocure Announces 43 Presentations on Tumor Treating Fields at 24th Annual Meeting of the Society for Neuro-Oncology406Presentations on Tumor Treating Fields cover a broad and growing range of topics, with nearly 80 percent of presentations prepared by external authors Novocure (NASDAQ: NVCR) today announced 43...
► Artikel lesen
01.11.19NovoCure Limited (NVCR) CEO Asaf Danziger on Q3 2019 Results - Earnings Call Transcript13
31.10.19NovoCure Limited 2019 Q3 - Results - Earnings Call Presentation10
Seite:  Weiter >>
47 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,3